Upside Potential Over 100% Have Analysts “Pounding The Table” On These 3 Stocks

Among the three stocks highlighted in today’s article where analysts at RBC see upside potential over 100% – and which have all earned “Strong Buy” consensus analyst ratings – is “a pharmaceutical company with a unique niche. The company focuses on developing medicinal treatments for the ears-nose-throat specialty.” For more on this stock (which analysts believe has upside potential over 300%) and the other two stocks RBC analysts believe have triple-digit upside potential, CLICK HERE.